AlphaFold predicted structure
CTLA4 · P16410

Mean pLDDT
80.1/ 100
Confident
223 residues
Confidence breakdown
- Very high(≥ 90)49%
- Confident(70–90)19%
- Low(50–70)23%
- Very low(< 50)9%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cytotoxic T-lymphocyte associated protein 4
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
COVID-19 research
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedGastrointestinal epithelial barrier disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownInfantile enterocolitis & monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntestinal failure or congenital diarrhoea
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPrimary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFamilial Meniere Disease
autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
Hashimoto thyroiditis
systemic lupus erythematosus
melanoma
non-small cell lung carcinoma
hepatocellular carcinoma
rheumatoid arthritis
hypothyroidism
type 1 diabetes mellitus
Graves disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Cytotoxic T-lymphocyte protein 4
Inhibitory receptor acting as a major negative regulator of T-cell responses (PubMed:11279501, PubMed:11279502, PubMed:16551244, PubMed:1714933, PubMed:18641304, PubMed:28484017). Acts as a decoy receptor: the affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28 (PubMed:11279501, PubMed:11279502, PubMed:16551244, PubMed:1714933, PubMed:28484017)
Curated MONDO disease pages that list CTLA4 among their top associated genes.
CTLA4 · P16410

Mean pLDDT
80.1/ 100
Confident
223 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0